Search Results

Tune-in as our expert discusses how and when to screen patients, and then connect them to available resources to better support patients’ financial needs.

In this episode, our experts examine challenges with oral anti-cancer therapies and provide methods to better support patients.

Hear how to educate patients and their caregivers about the risks and benefits to oral therapies for breast cancer.

Hear how malnutrition affects people with cancer in different ways, even impacting cancer treatment plans.

Hear how malnutrition affects people with cancer in different ways, even impacting cancer treatment plans.

With the emergence of oral cancer therapies, it is a very exciting time in cancer care. But these treatments can come with adverse events.

Listen to ACCC's Matt Devino and President of the Empire State Hematology & Oncology Society, Rahul Seth, DO, discuss why every voice is critical in grassroots advocacy efforts on both the federal and state level, and how cancer professionals who moonlight as patient advocates can help improve access to care and reduce financial toxicity for people living with cancer.

Hear how a virtual integrative format can enable cancer programs to adapt touch modalities to self-interventions, leverage opportunities for research, and overcome social and economic barriers.

As the COVID-19 pandemic recedes and restrictions loosens for most of the U.S., we'll discuss how patient education has become even more critical during this transition.

Learn how the entire cancer care team can help in promoting safe oral anti-cancer medication adherence by bridging gaps in patient education, management, and monitoring.

Learn about the latest promising breakthroughs in immunotherapy, the challenges facing their widespread use, and what your cancer team needs to know about the future of cancer treatment.

Learn about the role of the interdisciplinary cancer team in managing oral chemotherapy for patients with cancer, and discover how one cancer program has improved their workflow while keeping the patient at the center.

Miami Cancer Institute shares their unique approach to helping patients with cancer understand why biosimilars may be their best—and most cost-effective—option for treatment.

Learn about the ways cancer programs are working to reduce drug waste and curb the rising cost of cancer care.

We explore how the COVID-19 pandemic has affected patient access to oral oncolytics, and what cancer teams can do to help their patients.